Kubient Reports Fourth Quarter and Full Year 2022 Results
03/29/2023 - 04:05 PM
NEW YORK, March 29, 2023 (GLOBE NEWSWIRE) -- Kubient, Inc. (NasdaqCM: KBNT, KBNTW) (“Kubient” or the “Company”) , a cloud-based software platform for digital advertising, today reported financial results for the fourth quarter and full year ended December 31, 2022.
Fourth Quarter 2022 and Recent Operational Highlights
Released KAI 2.0, the latest update to its proprietary ad fraud identification and prevention technology including improvements such as: expanded real-time AI with 25 algorithms running in under 10 milliseconds and built-in efficiencies to significantly expand the number and complexity of algorithms in the future; full support for the much larger scale IPv6 protocol (to add to the existing IPv4 support); enhanced support for new CTV and audio formats; and more.Announced that the United States Patent and Trademark Office (“USPTO”) had issued its patent for the Company’s proprietary ad fraud identification and prevention technology, KAI.Launched the KAI Dashboard, a reporting and optimization platform that helps media publishers and platforms better understand and manage inventory health.Management Commentary
Full Year 2022 Financial Results $2.4 million compared to approximately $2.7 million in the same period last year. The decrease in total net revenues was primarily associated with a decrease of net revenues associated with a major customer as compared to the 2021 period, partially offset by revenues generated in the 2022 period related to customer contracts acquired in connection with the acquisition of MediaCrossing in November 2021.
Technology expenses increased to approximately $3.2 million from approximately $3.1 million in the same period last year. The increase was primarily attributable to initial increases in headcount costs in early 2022, stock-based compensation expenses, cloud hosting expenses, partially offset by decreases in technology programming fees, amortization expenses, consulting fees, software subscriptions and travel and entertainment expenses.
General and administrative expenses increased to approximately $6.6 million compared to approximately $6.1 million in the same period last year. The increase was primarily attributable to increases in legal and professional fees, stock-based compensation expenses, rent expenses, board fees, dues and memberships fees, state income tax expenses, travel and entertainment expenses, software subscriptions, partially offset by decreases in recruiting fees, consulting fees, insurance expenses, office related expenses, bad debt expenses and headcount costs.
GAAP net loss attributable to common shareholders was approximately $13.6 million , or $(0.95) loss per basic and diluted share, compared to a net loss of approximately $10.3 million , or $(0.75) loss per basic and diluted share, in the same period last year.
Adjusted EBITDA loss, a non-GAAP measure, was approximately $12.9 million , or $(0.90) per basic and diluted share for the full year ended December 31, 2022, compared to an adjusted EBITDA loss of approximately $9.2 million , or $(0.67) per basic and diluted share, in the same period last year.
As of December 31, 2022, the Company had a cash balance of approximately $14.7 million .
Conference Call
Kubient management will host the conference call, followed by a question and answer period.
Date: Wednesday, March 29, 2023
Please call the conference telephone number 10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Investor Relations at 949-574-3860.
The conference call will be broadcast live and available for replay here and via the Investor Relations section of Kubient’s website.
A telephonic replay of the conference call will be available after 7:30 p.m. Eastern time on the same day through April 12, 2023.
Toll-free replay number: 1-877-481-4010
About Kubient https://kubient.com .
Forward-Looking Statements
Non-GAAP Measures
EBITDA and Adjusted EBITDA are financial measures that are not calculated in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Management believes that because Adjusted EBITDA excludes (a) certain non-cash expenses (such as depreciation, amortization and stock-based compensation) and (b) expenses that are not reflective of the Company’s core operating results over time (such as stock based compensation expense), this measure provides investors with additional useful information to measure the Company’s financial performance, particularly with respect to changes in performance from period to period. The Company’s management uses EBITDA and Adjusted EBITDA (a) as a measure of operating performance, (b) for planning and forecasting in future periods, and (c) in communications with the Company’s board of directors concerning the Company’s financial performance. The Company’s presentation of EBITDA and Adjusted EBITDA are not necessarily comparable to other similarly titled captions of other companies due to different methods of calculation and should not be used by investors as a substitute or alternative to net income or any measure of financial performance calculated and presented in accordance with U.S. GAAP. Instead, management believes EBITDA and Adjusted EBITDA should be used to supplement the Company’s financial measures derived in accordance with U.S. GAAP to provide a more complete understanding of the trends affecting the business.
Although Adjusted EBITDA is frequently used by investors and securities analysts in their evaluations of companies, Adjusted EBITDA has limitations as an analytical tool, and investors should not consider it in isolation or as a substitute for, or more meaningful than, amounts determined in accordance with U.S. GAAP. Some of the limitations to using non-GAAP measures as an analytical tool are (a) they do not reflect the Company’s interest income and expense, or the requirements necessary to service interest or principal payments on the Company’s debt, (b) they do not reflect future requirements for capital expenditures or contractual commitments, and (c) although depreciation and amortization charges are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and non-GAAP measures do not reflect any cash requirements for such replacements.
Kubient Investor Relations Kubient@gatewayir.com
Kubient, Inc. Consolidated Statements of Operations (Unaudited)
For the Years Ended December 31, 2022 2021 Net Revenues $ 2,403,408 $ 2,737,767 Costs and Expenses: Sales and marketing 3,779,509 3,032,133 Technology 3,177,497 3,079,752 General and administrative 6,558,052 6,117,601 Loss on legal settlement - 880,381 Impairment loss on intangible assets 2,626,974 - Impairment loss on property and equipment 49,948 - Impairment loss on goodwill 463,000 - Total Costs and Expenses 16,654,980 13,109,867 Loss From Operations (14,251,572 ) (10,372,100 ) Other (Expense) Income: Interest expense (10,909 ) (8,383 ) Interest income 18,597 88,537 Change in fair value of contingent consideration 613,000 - Other income 11,000 233 Total Other Income 631,688 80,387 Net Loss $ (13,619,884 ) $ (10,291,713 ) Net Loss Per Share - Basic and Diluted $ (0.95 ) $ (0.75 ) Weighted Average Common Shares Outstanding - Basic and Diluted 14,319,060 13,695,700
Kubient, Inc. Consolidated Balance Sheets (Unaudited)
December 31, 2022 2021 Assets Current Assets: Cash and cash equivalents $ 14,739,484 $ 24,907,963 Accounts receivable, net 135,658 2,291,533 Other receivables - 526,070 Prepaid expenses and other current assets 346,935 495,178 Total Current Assets 15,222,077 28,220,744 Intangible assets, net - 2,946,610 Goodwill - 463,000 Property and equipment, net - 44,756 Deferred financing costs 10,000 10,000 Total Assets $ 15,232,077 $ 31,685,110 Liabilities and Stockholders' Equity Current Liabilities: Accounts payable - suppliers $ 673,781 $ 1,844,544 Accounts payable - trade 816,190 659,362 Accrued expenses and other current liabilities 830,365 2,493,287 Deferred revenue 28,403 395,914 Current portion of notes payable - 151,336 Total Current Liabilities 2,348,739 5,544,443 Contingent consideration - 613,000 Notes payable, non-current portion 78,900 77,407 Total Liabilities 2,427,639 6,234,850 Stockholders' Equity: Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of December 31, 2022 and 2021 - - Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,456,035 and 14,253,948 shares issued and outstanding as of December 31, 2022 and 2021, respectively 145 143 Additional paid-in capital 53,004,967 52,030,907 Accumulated deficit (40,200,674 ) (26,580,790 ) Total Stockholders' Equity 12,804,438 25,450,260 Total Liabilities and Stockholders' Equity $ 15,232,077 $ 31,685,110
Kubient, Inc. Consolidated Statements of Cash Flows (Unaudited)
For the Years Ended December 31, 2022 2021 Cash Flows From Operating Activities: Net loss $ (13,619,884 ) $ (10,291,713 ) Adjustments to reconcile net loss to net cash used in operating activities: Bad debt expense 7,000 22,698 Impairment loss on intangible assets 2,626,974 - Impairment loss on property and equipment 49,948 - Impairment loss on goodwill 463,000 - Depreciation and amortization 330,993 452,136 Change in fair value of contingent consideration (613,000 ) - Stock-based compensation: Common stock 982,647 700,652 Options 8,840 23,390 Changes in operating assets and liabilities: Accounts receivable 2,148,875 (940,477 ) Other receivable 507,387 3,955 Prepaid expenses and other current assets 506,109 73,491 Accounts payable - suppliers (1,170,763 ) 1,508,516 Accounts payable - trade 156,828 (447,242 ) Accrued expenses and other current liabilities (1,617,375 ) 1,467,306 Deferred revenue (367,511 ) (247,504 ) Net Cash Used In Operating Activities (9,599,932 ) (7,674,792 ) Cash Flows From Investing Activities: Purchase of intangible assets - (1,133,072 ) Purchase consideration of MediaCrossing - (500,000 ) Purchase of property and equipment (16,549 ) (39,414 ) Net Cash Used In Investing Activities (16,549 ) (1,672,486 ) Cash Flows From Financing Activities: Proceeds from exercise of warrants [1] - 9,787,149 Proceeds from exercise of options - 8,361 Repayment of PPP loan (149,843 ) (177,347 ) Repayment of financed director and officer insurance premiums (402,155 ) (145,050 ) Net Cash (Used In) Provided By Financing Activities (551,998 ) 9,473,113 Net (Decrease) Increase In Cash and Cash Equivalents (10,168,479 ) 125,835 Cash and Cash Equivalents - Beginning of the Period 24,907,963 24,782,128 Cash and Cash Equivalents - End of the Period $ 14,739,484 $ 24,907,963 [1] Includes gross proceeds of $10,169,027, less issuance costs of $381,878.
Kubient, Inc. Reconciliation of GAAP EBITDA to Non-GAAP Adjusted EBITDA (Unaudited)
For the Years Ended December 31, 2022 2021 Net Loss $ (13,619,884 ) $ (10,291,713 ) Interest expense 10,909 8,383 Interest income (18,597 ) (88,537 ) Change in fair value of contingent consideration (613,000 ) Depreciation and amortization 330,993 452,136 EBITDA (13,909,579 ) (9,919,731 ) Adjustments: Stock-based compensation expense 991,487 724,042 Adjusted EBITDA $ (12,918,092 ) $ (9,195,689 ) Adjusted Loss Per Share $ (0.90 ) $ (0.67 ) Weighted Average Common Shares Outstanding - Basic and Diluted 14,319,060 13,695,700
